Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00801554 · ClinicalTrials.gov registry record

Autism Spectrum Disorders (ASD) Characterization Study

A clinical trial of Autism Spectrum Disorders, sponsored by Massachusetts General Hospital.

Completed
Registry status
26
Enrollment target
1
Study location

NCT00801554 is a study of Autism Spectrum Disorders that has completed, run by Massachusetts General Hospital. The registered enrollment target is 26 participants, below the 167-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00801554, a study of Autism Spectrum Disorders, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
26 participants
Enrollment target
1
Study location

Study Summary

The overarching aim of the study is to characterize children and adults with ASDs, and compare them with age-matched controls in relation to their functioning in family, academic, employment, and social spheres. Subjects will be comprehensively assessed in multiple non-overlapping domains of functioning, using psychiatric, cognitive, and psychosocial instruments.

Conditions Studied

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Cambridge

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2008-10
Est. Completion 2010-04

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00801554

The ClinicalTrials.gov registry entry for NCT00801554 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 167-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (84% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT00801554 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00801554 about?

NCT00801554 is a clinical study titled "Autism Spectrum Disorders (ASD) Characterization Study". The overarching aim of the study is to characterize children and adults with ASDs, and compare them with age-matched controls in relation to their functioning in family, academic, employment, and social spheres. Subjects will be comprehensively assessed in multiple non-overlapping domains of functio...

What is the current status of trial NCT00801554?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-10. Estimated completion is 2010-04.

What conditions does trial NCT00801554 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

Who is sponsoring clinical trial NCT00801554?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00801554 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.